You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome

Article metrics

Article menu

Download PDFPDF

Research Article
Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome

 

Online download statistics by month:

Online download statistics by month: December 2019 to November 2024

AbstractFullPdf
Dec 2019110
Jan 2020661
Feb 202010104
Mar 2020661
Apr 2020661
May 202015153
Jun 2020772
Jul 202013132
Aug 2020330
Sep 202018183
Oct 202024241
Nov 202013135
Dec 202031313
Jan 202112125
Feb 202115156
Mar 2021771
Apr 202110104
May 202121210
Jun 202111111
Jul 202122225
Aug 2021776
Sep 202124249
Oct 202127277
Nov 202115146
Dec 202114144
Jan 2022671
Feb 2022991
Mar 202213132
Apr 202221225
May 202232326
Jun 202238385
Jul 202224256
Aug 202234345
Sep 202221215
Oct 202228288
Nov 2022212314
Dec 202218187
Jan 202329296
Feb 202330305
Mar 202320218
Apr 2023789
May 20237711
Jun 202314147
Jul 202361618
Aug 2023776
Sep 2023335
Oct 2023101012
Nov 202319195
Dec 202316164
Jan 202410111
Feb 202418198
Mar 2024303169
Apr 2024252517
May 2024252511
Jun 202427266
Jul 202434369
Aug 202425256
Sep 202431316
Oct 2024212114
Nov 202438416
Total11101123384